After conducting market inquiries, the ACCC determined that the acquisition of Washington Soul Pattinson's pharmaceutical wholesaling and manufacturing business by API would not substantially affect competition, on the basis that certain Undertakings would be provided by API to the ACCC. The Undertakings provide that API will not hinder or prevent a pharmacy in NSW to whom it supplies pharmaceutical goods and services from obtaining supplies of pharmaceutical goods and services from whatever source it desires. The Undertakings are for a period of 3 years.
